SGLT2 inhibitors not linked with improved survival in hospitalized COVID-19 patients
Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late breaking research presented ...
Aug 29, 2023
0
1